Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel molecular mechanism modulating osteoclast differentiation and function.

H Yasuda1, N Shima, N Nakagawa

  • 1Research Institute of Life Science, Snow Brand Milk Products Co. Ltd., Tochigi, Japan. fvbd7042@mb.infoweb.ne.jp

Bone
|July 28, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-dependent gene expression and immunohistochemical analysis of the injured anterior cruciate ligament.

Bone & joint research·2013
Same author

Knee osteoarthritis, knee joint pain and aging in relation to increasing serum hyaluronan level in the Japanese population.

Osteoarthritis and cartilage·2010
Same author

Acute coronary artery dilation due to Kawasaki disease and subsequent late calcification as detected by electron beam computed tomography.

Pediatric cardiology·2007
Same author

Two young adults who had acute coronary syndrome after regression of coronary aneurysms caused by Kawasaki disease in infancy.

Pediatric cardiology·2006
Same author

Pregnancy and delivery in patients with coronary artery lesions caused by Kawasaki disease.

Heart (British Cardiac Society)·2005
Same author

Strategy for localized stenosis caused by Kawasaki disease: midterm results of percutaneous transluminal coronary balloon angioplasty in two infants.

Pediatric cardiology·2005

Researchers discovered osteoclast differentiation factor (ODF), a key signaling molecule for bone-resorbing osteoclast formation. Osteoprotegerin (OPG) acts as a decoy receptor, blocking ODF and inhibiting osteoclast activity, revealing a new pathway for bone regulation.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Bone Biology

Background:

  • Osteoclasts, crucial for bone resorption, originate from monocyte/macrophage lineage cells.
  • Osteoblast and stromal cells support osteoclast development via cell-to-cell interactions.

Purpose of the Study:

  • To identify the ligand for osteoprotegerin (OPG)/osteoclastogenesis inhibitory factor (OCIF).
  • To elucidate the molecular mechanism regulating osteoclast differentiation and bone resorption.

Main Methods:

  • Screening of a cDNA expression library from ST2 cells treated with 1,25(OH)2D3 and dexamethasone.
  • In vitro assays using osteoclast progenitors and M-CSF.
  • Fetal mouse long bone culture system.

Main Results:

Related Experiment Videos

  • Identified osteoclast differentiation factor (ODF), a TNF ligand family member, which induces osteoclast formation.
  • ODF expression is upregulated by osteotropic factors (1,25(OH)2D3, PGE2, PTH, IL-11).
  • OPG/OCIF and anti-ODF antibody inhibit ODF-induced osteoclastogenesis and bone resorption.

Conclusions:

  • ODF is a critical ligand mediating osteoclast differentiation signals.
  • RANK is identified as the signaling receptor for ODF.
  • OPG/OCIF functions as a decoy receptor for ODF, regulating osteoclastogenesis and bone remodeling.